This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 48/6/1095    most recent 01.HYP.0000248211.82232.a7v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsushita, K. Articles by Dzau, V. J. Search for Related Content PubMed PubMed Citation Articles by Matsushita, K. Articles by Dzau, V. J. Related Collections Obesity Cardiovascular Pharmacology ACE/Angiotension receptors Developmental biology Gene expression Related Article

(Hypertension. 2006;48:1095.)
© 2006 American Heart Association, Inc.

Original Articles

Local Renin Angiotensin Expression Regulates Human Mesenchymal Stem Cell Differentiation to Adipocytes

Kenichi Matsushita; Yaojiong Wu; Yoshihisa Okamoto; Richard E. Pratt; Victor J. Dzau

From the Department of Medicine (K.M., Y.W., R.E.P., V.J.D.), Duke University Medical Center, Durham NC; and Cardiovascular Research Laboratories (K.M., Y.W., Y.O., R.E.P.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Victor J. Dzau, Office of the Chancellor, Duke University Medical Center, Durham, NC 27710. E-mail victor.dzau{at}duke.edu

Clinical and experimental evidence suggest that the renin–angiotensin system (RAS) plays a role in metabolic syndrome. Adipogenesis is suggested to modulate obesity and obesity-related consequences, such as metabolic syndrome. Although mesenchymal stem cells (MSCs) are a major source of adipocyte generation, the influence of RAS on MSC differentiation to adipocyte is unknown. We evaluated the expression of endogenous RAS in human MSCs during its differentiation to adipocytes and studied the effects of angiotensin II (Ang II), Ang II type 1 receptor blocker Valsartan, and type 2 (AT₂) receptor blocker PD123319. Our data showed that differentiation was associated with an increase in cellular renin and AT₂ receptor expression and a concomitant decrease in angiotensinogen and angiotensin-converting enzyme expression. The net effect is an increase in endogenous cellular angiotensin II production. Incubation with Ang II (exogenous) inhibited adipogenesis. Combined treatment of exogenous Ang II and Valsartan further inhibited adipogenesis, whereas combined treatment of Ang II and PD123319 completely abolished the inhibition of adipogenesis, suggesting an important role for the AT₂ receptor. Blockade of endogenous angiotensin II effect by incubation with Valsartan alone inhibited adipogenesis, whereas PD123319 alone promoted adipogenesis, confirming the data using exogenous Ang II. The combination of Valsartan and PD123319 had no net effect. Our data demonstrate an important role of the expression of the local RAS in the regulation of human MSC differentiation to adipocytes. Elucidation of the molecular mechanism should provide important insight into the pathophysiology of the metabolic syndrome and the development of future therapeutics.

Key Words: renin–angiotensin system • angiotensin II • mesenchymal stem cells • gene expression • adipose tissue • obesity

Related Article:

Emerging Concept of Adipogenesis Regulation by the Renin–Angiotensin System

Masaki Mogi, Masaru Iwai, and Masatsugu Horiuchi
Hypertension 2006 48: 1020-1022. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				Y. Tsubakimoto, H. Yamada, H. Yokoi, S. Kishida, H. Takata, H. Kawahito, A. Matsui, N. Urao, Y. Nozawa, H. Hirai, et al. Bone Marrow Angiotensin AT1 Receptor Regulates Differentiation of Monocyte Lineage Progenitors From Hematopoietic Stem Cells Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1529 - 1536. [Abstract] [Full Text] [PDF]

				L. Yvan-Charvet, F. Massiera, N. Lamande, G. Ailhaud, M. Teboul, N. Moustaid-Moussa, J.-M. Gasc, and A. Quignard-Boulange Deficiency of Angiotensin Type 2 Receptor Rescues Obesity But Not Hypertension Induced by Overexpression of Angiotensinogen in Adipose Tissue Endocrinology, March 1, 2009; 150(3): 1421 - 1428. [Abstract] [Full Text] [PDF]

				J. D. Fowler, S. B. Krueth, D. A. Bernlohr, and S. A. Katz Renin dynamics in adipose tissue: adipose tissue control of local renin concentrations Am J Physiol Endocrinol Metab, February 1, 2009; 296(2): E343 - E350. [Abstract] [Full Text] [PDF]

				M. Gupte, C. M. Boustany-Kari, K. Bharadwaj, S. Police, S. Thatcher, M. C. Gong, V. L. English, and L. A. Cassis ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R781 - R788. [Abstract] [Full Text] [PDF]

				M. Mogi, M. Iwai, and M. Horiuchi Emerging Concept of Adipogenesis Regulation by the Renin-Angiotensin System Hypertension, December 1, 2006; 48(6): 1020 - 1022. [Full Text] [PDF]